Literature DB >> 21164519

Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains.

M Ramaswamy1, A C Cruz, S Y Cleland, M Deng, S Price, V K Rao, R M Siegel.   

Abstract

Elimination of autoreactive CD4(+) T cells through the death receptor Fas/CD95 is an important mechanism of immunological self-tolerance. Fas deficiency results in systemic autoimmunity, yet does not affect the kinetics of T-cell responses to acute antigen exposure or infection. Here we show that Fas and TCR-induced apoptosis are largely restricted to CD4(+) T cells with an effector memory phenotype (effector memory T cells (T(EM))), whereas central memory and activated naïve CD4(+) T cells are relatively resistant to both. Sensitivity of T(EM) to Fas-induced apoptosis depends on enrichment of Fas in lipid raft microdomains, and is linked to more efficient formation of the Fas death-inducing signaling complex. These results explain how Fas can cull T cells reactive against self-antigens without affecting acute immune responses. This work also identifies Fas-induced apoptosis as a possible immunotherapeutic strategy to eliminate T(EM) linked to the pathogenesis of a number of autoimmune diseases.
© 2011 Macmillan Publishers Limited

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164519      PMCID: PMC3131900          DOI: 10.1038/cdd.2010.155

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27.

Authors:  Ruth D Fritsch; Xinglei Shen; Gary P Sims; Karen S Hathcock; Richard J Hodes; Peter E Lipsky
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

2.  Mature T lymphocyte apoptosis in the healthy and diseased immune system.

Authors:  L Zheng; G Fisher; B Combadiere; F Hornung; D Martin; C Pelfrey; J Wang; M Lenardo
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

Review 3.  An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Authors:  S E Straus; M Sneller; M J Lenardo; J M Puck; W Strober
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

4.  Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.

Authors:  F Petschner; C Zimmerman; A Strasser; D Grillot; G Nunez; H Pircher
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

Review 5.  Induction of tolerance using Fas ligand: a double-edged immunomodulator.

Authors:  Nadir Askenasy; Esma S Yolcu; Isaac Yaniv; Haval Shirwan
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

6.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

8.  Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.

Authors:  B Kovacs; D Vassilopoulos; S A Vogelgesang; G C Tsokos
Journal:  Clin Immunol Immunopathol       Date:  1996-12

9.  Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases.

Authors:  T Zhou; L Song; P Yang; Z Wang; D Lui; R S Jope
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

10.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

View more
  22 in total

Review 1.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

Review 2.  Autoimmune effector memory T cells: the bad and the good.

Authors:  Priyadharshini Devarajan; Zhibin Chen
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 3.  Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy.

Authors:  Fei Yi; Nicholas Frazzette; Anthony C Cruz; Christopher A Klebanoff; Richard M Siegel
Journal:  Trends Mol Med       Date:  2018-06-04       Impact factor: 11.951

4.  STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.

Authors:  Sonia S Majri; Jill M Fritz; Alejandro V Villarino; Lixin Zheng; Chrysi Kanellopoulou; Benjamin Chaigne-Delalande; Juha Grönholm; Julie E Niemela; Behdad Afzali; Matthew Biancalana; Stefania Pittaluga; Ashleigh Sun; José L Cohen; Steven M Holland; John J O'Shea; Gulbu Uzel; Michael J Lenardo
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

5.  Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

Authors:  Christopher A Klebanoff; Christopher D Scott; Anthony J Leonardi; Tori N Yamamoto; Anthony C Cruz; Claudia Ouyang; Madhu Ramaswamy; Rahul Roychoudhuri; Yun Ji; Robert L Eil; Madhusudhanan Sukumar; Joseph G Crompton; Douglas C Palmer; Zachary A Borman; David Clever; Stacy K Thomas; Shashankkumar Patel; Zhiya Yu; Pawel Muranski; Hui Liu; Ena Wang; Francesco M Marincola; Alena Gros; Luca Gattinoni; Steven A Rosenberg; Richard M Siegel; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

Review 6.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

7.  A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.

Authors:  Bernice Lo; Madhu Ramaswamy; Joie Davis; Susan Price; V Koneti Rao; Richard M Siegel; Michael J Lenardo
Journal:  J Clin Immunol       Date:  2012-10-11       Impact factor: 8.317

Review 8.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

9.  CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model.

Authors:  A Page; S Srinivasan; K Singh; M Russell; K Hamby; T Deane; S Sen; L Stempora; F Leopardi; A A Price; E Strobert; K A Reimann; A D Kirk; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

10.  Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection.

Authors:  Robert J Plenter; Todd J Grazia; David P Nelson; Martin R Zamora; Ronald G Gill; Biagio A Pietra
Journal:  Cell Immunol       Date:  2014-12-06       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.